UPMC Hillman Cancer Center | March 21, 2026

The Following Talks Hosted by: John M. Kirkwood, MD
Each presentation includes a 5-minute Q & A Session

Oncolytic Immunotherapy in the Treatment of Melanoma
Yana G. Najjar, MD
Associate Professor of Medicine
Director, Clinical and Translational Research Center
UPMC Hillman Cancer Center

Using Blood Proteins to Predict Immune Side Effects in Melanoma Patients Treated with Immunotherapy
Sabrina Bruno, BS
MS3, University of Pittsburgh School of Medicine

The Promise of Opiod Antagonist (Axelopran) as an Avenue to Overcome Immunotherapy Resistance in Melanoma
Nosakhare Paul Ilerhunmwuwa , MBBS, MSc
Fellow, UPMC Hillman Cancer Center

Background and Goals of a New Trial of Sulforaphane for Melanoma Prevention (EA6232)
Emma Kozuch, BS
MS3, University of Pittsburgh School of Medicine

The Following Talks Hosted By: Hassane M. Zarour, MD
Professor of Medicine, Immunology and Dermatology
James and Frances McGlothlin Chair in Melanoma Immunotherapy Research
Co-leader, Cancer Immunology and Immunotherapy Program
Co-leader, Melanoma and Skin Cancer SPORE
UPMC Hillman Cancer Center

From Plate to Patient: Dietary Influences on Immunotherapy
Diwakar Davar, MD
Associate Professor of Medicine
Clinical Director, Melanoma and Skin Cancer Program
UPMC Hillman Cancer

Dietary Interventions in Melanoma Patients
Ryan C. Camacho, BS
MS4, University of Pittsburgh School of Medicine

Role of Radiotherapy in Metastatic Melanoma
Ravi Patel, MD, PhD
Assistant Professor, Department of Radiation Oncology,
University of Pittsburgh
Director of Radiopharmaceuticals, UPMC Hillman Cancer Center

What You Need to Know About Sunscreens
Kathryn Hickey, MPAS, PA-C
Physician Assistant
UPMC Hillman Cancer Center